证券记录 · 已归档季度
PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
15被追踪持有人
—Δ持有人
10.85M持有股份
$278.70M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 113.09M | $1.17B | +10 | −7 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | — | — |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | — |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | — | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | — | −1 |
| Q2 2024 | 15 | — | 10.85M | $278.70M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 2.25M | — | $57.87M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 2.25M | — | $57.87M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.22M | — | $56.96M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 2.22M | — | $56.96M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (被动) | 1.37M | — | $35.11M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 970.64K | — | $24.93M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 970.64K | — | $24.93M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 970.64K | — | $24.93M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 819.55K | — | $21.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 819.55K | — | $21.05M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 819.55K | — | $21.05M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 797.09K | — | $20.47M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 762.41K | — | $19.58M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 451.92K | — | $11.61M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 436.65K | — | $11.21M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 273.20K | — | $7.02M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 249.42K | — | $6.41M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 108.37K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 108.37K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 91.47K | — | $2.35M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 39.17K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 14.20K | — | $364,656 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 326 持有人, 151.12M 股份, $1.41B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据